$TXTM take note:

$TXTM .0039 company confirms Deloitte onboarding is complete What happens to the share price when Dr J releases an official valuation report from Deloitte showing the enterprise value is magnitudes higher than current market cap? 👀 $505M assets, 0 debt ⏳💣

$GZIC .0005 (EM) with an amended annual report out today. This is usually done at the request of OTCM and is often the final step in getting current 🇨🇦 all required filings are posted otcmarkets.com/file/company/f…

$TXTM .0043 breaking out here. Solid buying pressure coming through. Pretty clear that the open-ended stock purchase program is ongoing. These shares purchased will never see the market again, essentially shrinking the float 👀 basic supply and demand ⬆️ x.com/Dr_Jamaloodeen…

$TXTM hope you took note 🔥

$TXTM .0049 on heavy volume. Walls getting blown up 💣 Might be the last chance to get real size at these levels. Someone is doing everything they can to keep it below .005. It’s only a matter of time before this breaks out to new highs that many thought were impossible ⏳

$TXTM received the web notification from the IR site. On iPhone, you can add ir.protext.com to your Home Screen as a web app. From there, open the web app and enable notifications to never miss another PR or announcement. Expecting some big ones soon 👀💣

$CAVR .0003 this one is flying under the radar. The official ex-dividend date has not been finalized yet for the PostBidShip spin out. Final details being worked out with FINRA. New website focusing on long term shareholder value. Great upside from these levels. Patience ⏳

$TXTM .0057 buy side volume continues to pour in. The seemingly unlimited shares at .0045-.0050 have been absorbed by Dr J and longs. So far, my prediction that .0050 was the last chance to get size is holding true 🔮 traded extremely thin EOD🔥

$GZIC .0006 out of the expert market. Only a 582M O/S on this shell. Will now be on watch for a merger 👀

$TXTM .0066 this has everything that the OTC has been waiting years for 🔥: ✅ Transparent company Protext Pharma ✅ No convertible debt / dilution ✅ Share buybacks by Dr J ✅ Balance sheet w/ $505M assets ✅ Dedicated following Don’t sleep on this one 👀

$TXTM these charts just keep getting better 🔥🔥 Stair stepping on the daily and weekly with increasing volume. Highest close since pre-CE in 2022 📈 this can be the kind of run that revives the entire OTC

$TXTM .0074 Deloitte valuation process continues to progress. 💰 $511M Assets vs $64M Market Cap 📕 0.058 Book Value per Share 🏷️ 87.3% Discount to Book What happens when Deloitte verifies everything on the balance sheet + a whole lot more 👀💣 discount won’t last forever ⌛️

$TXTM .0092 the buying continues, looks like the market is starting to believe 👀 Even if you ignore all the positive fundamentals, this can run off the fact that there is no dilution alone. Finally an OTC ticker where traders aren’t fighting against the company on the way up 📈

$TXTM .0089 with a textbook bounce off the 8-day MA and previous resistance level. Showing extreme strength with heavy volume. Look for the moving averages to start to catch up as it consolidates ⌛️ Everything is indicating that the battle for .01 is coming ⚔️

$TXTM .0088 consolidating in this range now as expected. Very healthy price action as the company continues to progress the Deloitte valuation + many other catalysts. 8-day MA has caught up and is acting as support Deloitte report release or any other big PR will send this 💣

$CAVR .0003 merger with PBS is complete. Still awaiting ex-div date from FINRA. Buying CAVR at .0003 is essentially buying shares of the new PBS company at a cost basis of 0.615. If PBS IPOs at $4, that's a 550% gain on the spin out shares👀

$LTNC filling some .0001. Pure lotto at this point.